MK-1403
/ Merck (MSD)
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
September 17, 2026
A Clinical Trial of MK-1403 in Healthy Participants (MK-1403-007)
(clinicaltrials.gov)
- P1 | N=15 | Active, not recruiting | Sponsor: Merck Sharp & Dohme LLC | Recruiting ➔ Active, not recruiting
Enrollment closed
September 16, 2026
A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)
(clinicaltrials.gov)
- P1 | N=53 | Completed | Sponsor: Merck Sharp & Dohme LLC | Active, not recruiting ➔ Completed
Trial completion • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
August 20, 2026
A Clinical Trial of MK-1403 in Healthy Participants (MK-1403-007)
(clinicaltrials.gov)
- P1 | N=15 | Recruiting | Sponsor: Merck Sharp & Dohme LLC | Not yet recruiting ➔ Recruiting
Enrollment open
August 18, 2026
A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)
(clinicaltrials.gov)
- P1 | N=52 | Active, not recruiting | Sponsor: Merck Sharp & Dohme LLC | Recruiting ➔ Active, not recruiting
Enrollment closed • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
1 to 4
Of
4
Go to page
1